ClinicalTrials.Veeva

Menu

The Fate of Aortic Valve After SAS Surgery in Children

C

Chinese Academy of Medical Sciences, Fuwai Hospital

Status

Completed

Conditions

Aortic Regurgitation
Congenital Heart Disease
Subaortic Stenosis

Study type

Observational

Funder types

Other

Identifiers

NCT06751368
2022-1727

Details and patient eligibility

About

Aortic valve regurgitation (AR) is a common complication following surgery for subaortic stenosis (SAS), yet the long-term outcomes and risk factors for postoperative significant AR (SAR) remain poorly understood. This study aims to investigate the incidence and risk factors of SAR in SAS patients and evaluate the long-term postoperative outcomes.

Enrollment

232 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 0-18
  • Clinical diagnosis of subaortic stenosis and underwent surgery

Exclusion criteria

  • Diagnosed with hypertrophic cardiomyopathy
  • Underwent concomitant previous surgical repair for aortic valve or SAS
  • Follow-up time less than 1 year or lack of detailed information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems